GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JTEC Corporation (TSE:3446) » Definitions » Net Income From Continuing Operations

JTEC (TSE:3446) Net Income From Continuing Operations : 円-11 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is JTEC Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. JTEC's net income from continuing operations for the three months ended in Mar. 2024 was 円-47 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was 円-11 Mil.

JTEC Net Income From Continuing Operations Historical Data

The historical data trend for JTEC's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JTEC Net Income From Continuing Operations Chart

JTEC Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Income From Continuing Operations
Get a 7-Day Free Trial 495.59 24.76 - -28.02 361.57

JTEC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 140.33 195.54 -74.80 -84.00 -47.30

JTEC Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JTEC (TSE:3446) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JTEC Corporation (TSE:3446) » Definitions » Net Income From Continuing Operations
Comparable Companies
TSE:7702 TSE:7775 TSE:3154 TSE:7980 TSE:3604 TSE:4556 TSE:7743 TSE:9340 TSE:7782 TSE:7979 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
2-5-38 Saito-Yamabuki, Ibaraki-shi, Osaka, JPN, 567-0086
Website
https://www.j-tec.co.jp
JTEC Corporation is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.

JTEC (TSE:3446) Headlines

No Headlines